Cargando…
CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite s...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818882/ https://www.ncbi.nlm.nih.gov/pubmed/36612204 http://dx.doi.org/10.3390/cancers15010206 |
_version_ | 1784865094757253120 |
---|---|
author | Karjula, Topias Elomaa, Hanna Niskakangas, Anne Mustonen, Olli Puro, Iiris Kuopio, Teijo Ahtiainen, Maarit Mecklin, Jukka-Pekka Seppälä, Toni T. Wirta, Erkki-Ville Sihvo, Eero Väyrynen, Juha P. Yannopoulos, Fredrik Helminen, Olli |
author_facet | Karjula, Topias Elomaa, Hanna Niskakangas, Anne Mustonen, Olli Puro, Iiris Kuopio, Teijo Ahtiainen, Maarit Mecklin, Jukka-Pekka Seppälä, Toni T. Wirta, Erkki-Ville Sihvo, Eero Väyrynen, Juha P. Yannopoulos, Fredrik Helminen, Olli |
author_sort | Karjula, Topias |
collection | PubMed |
description | SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite stable CRC. The T-cell infiltration was higher in the first pulmonary metastases compared to primary tumour. Pulmonary metastases with high ICS had improved survival compared to low ICS after adjusting for confounders. High tumour cell PD-L1 expression was associated with favourable prognosis. Our results might have clinical feasibility in planning future therapies. ABSTRACT: The objective of this study was to evaluate the prognostic value of CD3(+) and CD8(+) based immune cell score (ICS), programmed death -1 (PD-1) and programmed death ligand -1 (PD-L1) in pulmonary metastases of proficient mismatch repair colorectal cancer (CRC) patients. A total of 101 pulmonary metastases and 62 primary CRC tumours were stained for CD3(+), CD8(+), PD-1 and PD-L1 expression. The prognostic value of ICS, PD-1/PD-L1 expression in 67 first pulmonary metastases and 61 primary CRC tumour was analysed. Comparative analysis was also performed between primary tumours and pulmonary metastases, as well as between T-cell densities and PD-1/PD-L1 expression. The 5-year overall survival rates of low, intermediate, and high ICS in pulmonary metastases were 10.0%, 25.5% and 47.0% (p = 0.046), respectively. Patients with high vs. low ICS in pulmonary metastases had a significantly better 5-year survival (adjusted HR 0.25, 95% CI 0.09–0.75, p = 0.013). High tumour cell PD-L1 expression in the pulmonary metastases was associated with improved survival (p = 0.024). Primary tumour CD8(+) expression was significantly correlated with all T-cell densities in pulmonary metastases. Conclusion: The ICS evaluated from the resected pulmonary metastases of CRC showed significant prognostic value. High PD-L1 expression in pulmonary metastases is associated with favourable prognosis. |
format | Online Article Text |
id | pubmed-9818882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98188822023-01-07 CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer Karjula, Topias Elomaa, Hanna Niskakangas, Anne Mustonen, Olli Puro, Iiris Kuopio, Teijo Ahtiainen, Maarit Mecklin, Jukka-Pekka Seppälä, Toni T. Wirta, Erkki-Ville Sihvo, Eero Väyrynen, Juha P. Yannopoulos, Fredrik Helminen, Olli Cancers (Basel) Article SIMPLE SUMMARY: The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3(+) and CD8(+) T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite stable CRC. The T-cell infiltration was higher in the first pulmonary metastases compared to primary tumour. Pulmonary metastases with high ICS had improved survival compared to low ICS after adjusting for confounders. High tumour cell PD-L1 expression was associated with favourable prognosis. Our results might have clinical feasibility in planning future therapies. ABSTRACT: The objective of this study was to evaluate the prognostic value of CD3(+) and CD8(+) based immune cell score (ICS), programmed death -1 (PD-1) and programmed death ligand -1 (PD-L1) in pulmonary metastases of proficient mismatch repair colorectal cancer (CRC) patients. A total of 101 pulmonary metastases and 62 primary CRC tumours were stained for CD3(+), CD8(+), PD-1 and PD-L1 expression. The prognostic value of ICS, PD-1/PD-L1 expression in 67 first pulmonary metastases and 61 primary CRC tumour was analysed. Comparative analysis was also performed between primary tumours and pulmonary metastases, as well as between T-cell densities and PD-1/PD-L1 expression. The 5-year overall survival rates of low, intermediate, and high ICS in pulmonary metastases were 10.0%, 25.5% and 47.0% (p = 0.046), respectively. Patients with high vs. low ICS in pulmonary metastases had a significantly better 5-year survival (adjusted HR 0.25, 95% CI 0.09–0.75, p = 0.013). High tumour cell PD-L1 expression in the pulmonary metastases was associated with improved survival (p = 0.024). Primary tumour CD8(+) expression was significantly correlated with all T-cell densities in pulmonary metastases. Conclusion: The ICS evaluated from the resected pulmonary metastases of CRC showed significant prognostic value. High PD-L1 expression in pulmonary metastases is associated with favourable prognosis. MDPI 2022-12-29 /pmc/articles/PMC9818882/ /pubmed/36612204 http://dx.doi.org/10.3390/cancers15010206 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karjula, Topias Elomaa, Hanna Niskakangas, Anne Mustonen, Olli Puro, Iiris Kuopio, Teijo Ahtiainen, Maarit Mecklin, Jukka-Pekka Seppälä, Toni T. Wirta, Erkki-Ville Sihvo, Eero Väyrynen, Juha P. Yannopoulos, Fredrik Helminen, Olli CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title | CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title_full | CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title_fullStr | CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title_full_unstemmed | CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title_short | CD3(+) and CD8(+) T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer |
title_sort | cd3(+) and cd8(+) t-cell-based immune cell score and pd-(l)1 expression in pulmonary metastases of microsatellite stable colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818882/ https://www.ncbi.nlm.nih.gov/pubmed/36612204 http://dx.doi.org/10.3390/cancers15010206 |
work_keys_str_mv | AT karjulatopias cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT elomaahanna cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT niskakangasanne cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT mustonenolli cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT puroiiris cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT kuopioteijo cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT ahtiainenmaarit cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT mecklinjukkapekka cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT seppalatonit cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT wirtaerkkiville cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT sihvoeero cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT vayrynenjuhap cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT yannopoulosfredrik cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer AT helminenolli cd3andcd8tcellbasedimmunecellscoreandpdl1expressioninpulmonarymetastasesofmicrosatellitestablecolorectalcancer |